Pulmocare Pharmaceutical Llp - Company Profile

It is a pharma limited liability partnership based in Nagpur, Maharashtra, India, established in 2023.
2023 Nagpur, Maharashtra, India Active
Last Updated:
Access Report
About Pulmocare Pharmaceutical Llp

Pulmocare Pharmaceutical Llp, a active limited liability partnership, was established on 31 August 2023 in Nagpur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds LLPIN: ACC-7592. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹10.00 K .

Its leadership includes Pranjali Hemant Balapure (Designated Partner), Mayank Hemant Balapure (Designated Partner). Past directors included Swapnil Ishwar Bakamwar, Parimal Shriniwas Deshpande. Its latest date of accounts and solvency statement 31 March 2025. It is based at Plot No. 4/A Ashtavinayak, Nagar, Nagpur (Urban), Nagpur, Maharashtra, 440036.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ACC-7592

  • Incorporation Date

    31 August 2023

  • Total Obligation of Contribution

    ₹10.00 K

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 10.00 K
  • Company Age 2 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Pulmocare Pharmaceutical Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Pulmocare Pharmaceutical Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Pulmocare Pharmaceutical Llp?
Current Designated Partners
Name Designation Appointment Date Status
Pranjali Hemant Balapure Designated Partner 31 Aug 2023 Current
Mayank Hemant Balapure Designated Partner 24 Nov 2025 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 24 Nov 2025 Past
Pramod Abcsdd Designated Partner 24 Nov 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Pulmocare Pharmaceutical Llp.

Enhance accessibility to Pulmocare Pharmaceutical Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Pulmocare Pharmaceutical Llp revenue growth over time
Pulmocare Pharmaceutical Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Pulmocare Pharmaceutical Llp?

Unlock access to Pulmocare Pharmaceutical Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Pulmocare Pharmaceutical Llp?

Unlock and access historical data on people associated with Pulmocare Pharmaceutical Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pulmocare Pharmaceutical Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pulmocare Pharmaceutical Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Pulmocare Pharmaceutical Llp
Recent Activity within the Organization
  • Director Appointment

    Mayank Hemant Balapure was appointed as a Designated Partner was appointed as a Designated Partner on 24 Nov 2025 & has been associated with this company since 3 months 25 days . was recorded as a recent event.

  • Annual General Meeting

    The activity Pulmocare Pharmaceutical Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    The activity Pulmocare Pharmaceutical Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Director Appointment

    Progress on Pranjali Hemant Balapure was appointed as a Designated Partner was appointed as a Designated Partner on 31 Aug 2023 & has been associated with this company since 2 years 6 months . was documented.

  • LLP Incorporation

    The activity Pulmocare Pharmaceutical Llp was registered on 31 Aug 2023 with Roc Mumbai & aged 2 years 6 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Pulmocare Pharmaceutical Llp?

The LLPIN of Pulmocare Pharmaceutical Llp is ACC-7592.

Where is Pulmocare Pharmaceutical Llp headquartered?

Pulmocare Pharmaceutical Llp is headquartered at Plot No. 4/A Ashtavinayak, Nagar, Nagpur (Urban), Nagpur, Maharashtra, 440036.

When was Pulmocare Pharmaceutical Llp incorporated?

Pulmocare Pharmaceutical Llp was incorporated on 31 August 2023.

Who are the current directors of Pulmocare Pharmaceutical Llp?

The current directors of Pulmocare Pharmaceutical Llp are

What is the primary industry of Pulmocare Pharmaceutical Llp?

The primary industry of Pulmocare Pharmaceutical Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available